The members of the Hemophilia Inhibitor Research Study Investigators are listed in the appendix.
ORIGINAL ARTICLE Inhibitors
F8 and F9 mutations in US haemophilia patients: correlation with history of inhibitor and race/ethnicity
Version of Record online: 21 NOV 2011
© 2011 Blackwell Publishing Ltd
Volume 18, Issue 3, pages 375–382, May 2012
How to Cite
MILLER, C. H., BENSON, J., ELLINGSEN, D., DRIGGERS, J., PAYNE, A., KELLY, F. M., SOUCIE, J. M., CRAIG HOOPER, W. and THE HEMOPHILIA INHIBITOR RESEARCH STUDY INVESTIGATORS (2012), F8 and F9 mutations in US haemophilia patients: correlation with history of inhibitor and race/ethnicity. Haemophilia, 18: 375–382. doi: 10.1111/j.1365-2516.2011.02700.x
- Issue online: 25 APR 2012
- Version of Record online: 21 NOV 2011
- Accepted after revision 23 October 2011
Figure S1.F8 mutations observed in haemophilia A patients. Bar length represents severity of disease (severe <1 IU dL−1, moderate 1–5 IU dL−1, mild >5 IU dL−1). Dashed bars indicate observation of heterogeneous severity. Width of bar indicates relative number of mutations seen.
Table S1.F8 mutations observed.
Table S2. Subjects with two potential mutations.
Table S3.F9 mutations.
|HAE_2700_sm_TableS1-S3-FigS1.doc||648K||Supporting info item|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.